Virtual Medicinal Product (VMP) - Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device

Navigation

Name Details

Name Start Date End Date
Name Current Name Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device Start Date 22-10-2020 End Date
Abbreviated Name Abbreviated Name Indacaterol 125microg/Mometasone 260microg/dose pdr caps Start Date 22-10-2020

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
capsule
Unit Dose UOM
capsule

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Inhalation
Form
Inhalation powder
Ontology Form/Route
powderinhalation.inhalation
Non-availability Indicator
Actual Products not Available
Name Basis
Other

Codes

ATC Code
R03AK14
BNF Codes
  • BNF code 03020000
SNOMED Codes
Code Start Date End Date
39116411000001105 22-10-2020

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Indacaterol acetate Based on Base Substance Indacaterol 125 microgram 1 dose
Mometasone furoate Based on Ingredient Substance 260 microgram 1 dose

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
30 capsule 2797 Part VIIIA Category C